Forward Pharma A/S (FWPAY) Research

Forward Pharma A/S presently engages in very limited business activities. In the past, this biopharmaceutical firm concentrated its efforts on developing FP187, its distinctive formulation of dimethyl fumarate, which was aimed at addressing both inflammatory and neurological conditions. The company was founded in 2005 and its headquarters are located in Copenhagen, Denmark.

Market snapshot

Symbol
FWPAY
Price
$300
Day change
-25.09%
Market cap
$48.6M
P/E ratio
2118.18x
52-week range
200.0-882.85626
Sector
Healthcare
Industry
Biotechnology

Peer companies

  • Bionomics Limited (BNOEF)
  • Carebook Technologies Inc. (CRBKF)
  • The Flowr Corporation (FLWPF)
  • HealthBeacon plc (HBCNF)
  • Immune Therapeutics, Inc. (IMUN)
  • Intellipharmaceutics International Inc. (IPCIF)
  • Polydex Pharmaceuticals Limited (POLXF)
  • Pascal Biosciences Inc. (PSCBF)

Open Forward Pharma A/S (FWPAY) in Thesis for live fundamentals, charts, options context, and portfolio-aware Copilot follow-ups.